Translating Bioinformatics in Oncology: Guilt-by-profiling Analysis and Identification of KIF18B and CDCA3 As Novel Driver Genes in Carcinogenesis
Overview
Authors
Affiliations
Motivation: Co-regulated genes are not identified in traditional microarray analyses, but may theoretically be closely functionally linked [guilt-by-association (GBA), guilt-by-profiling]. Thus, bioinformatics procedures for guilt-by-profiling/association analysis have yet to be applied to large-scale cancer biology. We analyzed 2158 full cancer transcriptomes from 163 diverse cancer entities in regard of their similarity of gene expression, using Pearson's correlation coefficient (CC). Subsequently, 428 highly co-regulated genes (|CC| ≥ 0.8) were clustered unsupervised to obtain small co-regulated networks. A major subnetwork containing 61 closely co-regulated genes showed highly significant enrichment of cancer bio-functions. All genes except kinesin family member 18B (KIF18B) and cell division cycle associated 3 (CDCA3) were of confirmed relevance for tumor biology. Therefore, we independently analyzed their differential regulation in multiple tumors and found severe deregulation in liver, breast, lung, ovarian and kidney cancers, thus proving our GBA hypothesis. Overexpression of KIF18B and CDCA3 in hepatoma cells and subsequent microarray analysis revealed significant deregulation of central cell cycle regulatory genes. Consistently, RT-PCR and proliferation assay confirmed the role of both genes in cell cycle progression. Finally, the prognostic significance of the identified KIF18B- and CDCA3-dependent predictors (P = 0.01, P = 0.04) was demonstrated in three independent HCC cohorts and several other tumors. In summary, we proved the efficacy of large-scale guilt-by-profiling/association strategies in oncology. We identified two novel oncogenes and functionally characterized them. The strong prognostic importance of downstream predictors for HCC and many other tumors indicates the clinical relevance of our findings.
Supplementary Information: Supplementary data are available at Bioinformatics online.
Zhao Y, He M, Cui L, Zhang M, Zhao T, Yang X BMC Cancer. 2024; 24(1):1243.
PMID: 39379897 PMC: 11462902. DOI: 10.1186/s12885-024-12999-9.
CDCA gene family promotes progression and prognosis in lung adenocarcinoma.
Liu X, Zhu X, Zhao Y, Shan Y, Gao Z, Yuan K Medicine (Baltimore). 2024; 103(24):e38581.
PMID: 38875380 PMC: 11175971. DOI: 10.1097/MD.0000000000038581.
The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside.
Zhao K, Li X, Feng Y, Wang J, Yao W Biomark Res. 2024; 12(1):30.
PMID: 38433242 PMC: 10910842. DOI: 10.1186/s40364-024-00559-z.
Hou J, Jia X, Xie Y, Qin W Genes (Basel). 2022; 13(10).
PMID: 36292654 PMC: 9601633. DOI: 10.3390/genes13101770.
Xie J, Wang B, Luo W, Li C, Jia X J Clin Lab Anal. 2022; 36(10):e24633.
PMID: 36085568 PMC: 9550975. DOI: 10.1002/jcla.24633.